抗病毒治疗进展讲解材料.pptVIP

艾滋病抗病毒治疗进展;;;对于初治成人患者的推荐方案 ;;DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. April 2015. Available at: /contentfiles/lvguidelines/adultandadolescentgl.pdf [accessed May 2015];DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. April 2015. Available at: /contentfiles/lvguidelines/adultandadolescentgl.pdf [accessed May 2015];DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. April 2015. Available at: /contentfiles/lvguidelines/adultandadolescentgl.pdf [accessed May 2015];DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. April 2015. Available at: /contentfiles/lvguidelines/adultandadolescentgl.pdf [accessed May 2015];DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. April 2015. Available at: /contentfiles/lvguidelines/adultandadolescentgl.pdf [accessed May 2015];;;抗逆转录病毒暴露及骨质疏松骨折风险：HAART 时期;计算骨质减少的FRAX 得分以确定是否需要药物治疗: 若髋部风险Fx 3%或Fx总风险20%，则Tx;现有免费药品挑战-不良反应;DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. April 2015. Available at: /contentfiles/lvguidelines/adultandadolescentgl.pdf [accessed May 2015];EACS Guidelines version 7.1. Nov 2014. Available at: /guidelines/update-71.html [accessed May 2015];EACS Guidelines version 7.1. Nov 2014. Available at: /guidelines/update-71.html [accessed May 2015];;ATV(阿扎那韦)200/RTV(利托那韦) 100mg vs. ATV 300mg/RTV 100mg ;Source: UNAIDS, gap report;;HIV/AIDS 抗病毒治疗的历史与现状;抗病毒每日1次合剂方案商品名药物组合上市时间;GS 934研究: TDF+FTC+EFV, 3 种服药方式的依从性分析;LifeLink 数据库中的患者依从性*;Cohen C, et al. HIV-11 2012; Glasgow, UK. P1;;*;;*;*;*;*;治疗作为预防; *;通过早期抗病毒治疗来预防HIV传播;在ART后稳定抑制病毒后，未发现伴侣间HIV传播;*;PrEP继续获得广泛支持;*;抗艾滋阴道环 ;性暴露前预防研究;性暴露前预防研究;HPTN 067/ADAPT:曼谷队列对PrEP 策略依从性;抗病毒治疗作为预防：WHO模式;UNAIDS: 90-90-90 治疗目标; UNAIDS: 90-90-90 全球估计差距;谢谢！